Please note, this OEL/ADE monograph also applies to Levamlodipine maleate (CAS RN 135969-53-8), Levamlodipine besylate (CAS RN 150566-71-5), Levamlodipine nicotinate (CAS RN 675605-61-5), Levamlodipine gentisate (CAS RN 856256-16-1), Levamlodipine benzoate (CAS RN 865361-13-3), Levamlodipine hydrochloride (CAS RN 865430-76-8), and Levamlodipine hydrobromide (CAS RN 865430-78-0). Levamlodipine, also known as S-amlodipine, is a pharmacologically active enantiomer of amlodipine, an antihypertensive medication. Levamlodipine belongs to the dihydropyridine group of calcium channel blockers. Levamlodipine is indicated alone or in combination to treat hypertension in adults and children.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Levamlodipine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.